• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从U937细胞中鉴定和稳定化大分子量磷酸二酯酶-Ⅳ

Identification and stabilization of large molecular weight PDE-IVs from U937 cells.

作者信息

DiSanto M E, Heaslip R J

机构信息

Division of Inflammation, Wyeth-Ayerst Research, Princeton, NJ 08543-8000.

出版信息

Biochem Biophys Res Commun. 1993 Dec 30;197(3):1126-31. doi: 10.1006/bbrc.1993.2594.

DOI:10.1006/bbrc.1993.2594
PMID:8280127
Abstract

Cytosolic cyclic nucleotide phosphodiesterases (PDEs) from human (promonocytic) U937 cells were rapidly resolved by DEAE-Sepharose CL-6B anion exchange chromatography into two major peaks of cAMP-specific activity possessing average Kms of 1.70 microM (Peak 1) and 1.65 microM (Peak 2). Both peaks were predominantly PDE-IV, but possessed molecular weights higher than those generally reported for partially purified PDE-IVs. Storage of Peak 2 for 24 h at 4 degrees C resulted in a doubling of its Vmax and an apparent decrease in its molecular weight. Activation of Peak 2 PDE-IV was prevented when the sodium acetate concentration in its buffer was reduced by dilution immediately following isolation. Although the relevance of this activation to cellular regulation of PDE-IV is undefined, the isolation and stabilization of PDE-IV in its large molecular weight form will be critical to future investigations of PDE-IV regulation.

摘要

通过DEAE-琼脂糖CL-6B阴离子交换色谱法,可将人(前单核细胞)U937细胞中的胞质环核苷酸磷酸二酯酶(PDEs)快速分离为两个具有cAMP特异性活性的主要峰,其平均Km值分别为1.70微摩尔(峰1)和1.65微摩尔(峰2)。这两个峰主要是PDE-IV,但分子量高于部分纯化的PDE-IV通常报道的分子量。将峰2在4℃下储存24小时,其Vmax增加一倍,分子量明显降低。分离后立即通过稀释降低其缓冲液中的乙酸钠浓度时,可防止峰2的PDE-IV激活。尽管这种激活与PDE-IV的细胞调节的相关性尚不清楚,但以其大分子形式分离和稳定PDE-IV对于未来PDE-IV调节的研究至关重要。

相似文献

1
Identification and stabilization of large molecular weight PDE-IVs from U937 cells.从U937细胞中鉴定和稳定化大分子量磷酸二酯酶-Ⅳ
Biochem Biophys Res Commun. 1993 Dec 30;197(3):1126-31. doi: 10.1006/bbrc.1993.2594.
2
Characterization of phosphodiesterase 4 in guinea-pig macrophages: multiple activities, association states and sensitivity to selective inhibitors.豚鼠巨噬细胞中磷酸二酯酶4的特性:多种活性、缔合状态及对选择性抑制剂的敏感性
Br J Pharmacol. 1998 May;124(1):129-40. doi: 10.1038/sj.bjp.0701819.
3
Purification and physical characterization of cloned human cAMP phosphodiesterases PDE-4D and -4C.克隆的人环磷酸腺苷磷酸二酯酶PDE-4D和-4C的纯化及物理特性分析
Cell Biochem Biophys. 1998;28(2-3):187-217. doi: 10.1007/BF02737811.
4
Refolding and purification of recombinant human PDE7A expressed in Escherichia coli as inclusion bodies.以包涵体形式在大肠杆菌中表达的重组人磷酸二酯酶7A的复性与纯化。
Protein Expr Purif. 2002 Jun;25(1):138-48. doi: 10.1006/prep.2002.1620.
5
[Cyclic AMP-specific nucleotide phosphodiesterase from the insoluble fraction of the human brain].[来自人脑不溶性部分的环磷酸腺苷特异性核苷酸磷酸二酯酶]
Biokhimiia. 1995 May;60(5):694-708.
6
Cyclic AMP-dependent phosphodiesterase isozyme-specific potentiation by protein kinase C in hypertrophic cardiomyopathic hamster hearts.蛋白激酶C对肥厚型心肌病仓鼠心脏中环磷酸腺苷依赖性磷酸二酯酶同工酶的特异性增强作用。
Mol Pharmacol. 1996 Sep;50(3):549-55.
7
Effect of streptozotocin-induced diabetes on phosphodiesterase activity in rat luteal cells.链脲佐菌素诱导的糖尿病对大鼠黄体细胞磷酸二酯酶活性的影响。
Mol Reprod Dev. 1996 Sep;45(1):43-7. doi: 10.1002/(SICI)1098-2795(199609)45:1<43::AID-MRD6>3.0.CO;2-S.
8
Regulation of cAMP phosphodiesterases by cyclic nucleotides in rat parotid gland.环核苷酸对大鼠腮腺中cAMP磷酸二酯酶的调节作用
Biochem Mol Biol Int. 1995 Dec;37(6):1029-36.
9
Further studies on the phosphorylation-regulated cAMP-phosphodiesterase from the dimorphic fungus Mucor rouxii.对双态真菌鲁氏毛霉中磷酸化调节的环磷酸腺苷磷酸二酯酶的进一步研究。
Second Messengers Phosphoproteins. 1988;12(5-6):289-99.
10
Isolation and regulation of the cGMP-inhibited cAMP phosphodiesterase in human erythroleukemia cells.人红白血病细胞中cGMP抑制的cAMP磷酸二酯酶的分离与调控
Thromb Haemost. 1997 Jan;77(1):155-62.

引用本文的文献

1
Novel thalidomide analogues display anti-angiogenic activity independently of immunomodulatory effects.新型沙利度胺类似物显示出独立于免疫调节作用的抗血管生成活性。
Br J Cancer. 2002 Nov 4;87(10):1166-72. doi: 10.1038/sj.bjc.6600607.